BrightCure Companies

BrightCure works on the development of novel treatment and prevention therapies for patients suffering from recurrent and chronic urinary tract infections (UTIs). The company's probiotic products continuously protect, restore, and balance intimate skin for a healthy urinary tract. BrightCure allows the treatment of biofilms and antibiotic-resistant strains overcoming the current therapy limitations and harmful side-effects associated with antibiotic therapies and aims to develop a healthy, effective, and accessible therapy solution for urinary tract infections (UTIs). It was founded in 2019 and is headquartered in London, England.
Industry: Community and Lifestyle, Health Care
Headquarters: London, England, United Kingdom
Founded Date: 2019-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 2
Last Funding Type: Convertible Note

Visit Website
https://twitter.com/Brightcure1
Register and Claim Ownership